Noninvasive imaging methods for evaluating cardiovascular involvement in patients with rheumatoid arthritis before and after anti-TNF drug treatment

Fabiola Atzeni, Luigi Gianturco, Laura Boccassini, Piercarlo Sarzi-Puttini, Gianluca Bonitta, Maurizio Turiel

Research output: Contribution to journalArticle

Abstract

Aim: To use 2D speckle-tracking echocardiography, and conventional and tissue Doppler echocardiography to detect subclinical left ventricular myocardial dysfunction in patients with rheumatoid arthritis (RA). Methods: Thirty RA outpatients were assessed before and after 18 months of treatment with anti-TNF drugs, along with 30 healthy controls. Cardiovascular risk was assessed by means of ultrasound carotid assessment and comprehensive echocardiographic evaluation (conventional and speckle-tracking calculation). Results: The speckle-tracking analyses were significantly different between the two groups, with global longitudinal strain deformation in the apical four-chamber view being significantly lower in the RA patients (median: 18.78%, interquartile range [IQR]: 15.80-20.82% vs 20.16%, IQR: 19.03-21.89%; [p < 0.05]). After 18 months of biological treatment, global longitudinal strain showed a significant improvement (18.78%, IQR: 15.80-20.82 vs 19.24%, IQR: 18.23-19.98; [p < 0.01]), such as for DAS28 (4.80, IQR: 4.65-5.22 vs 2.78; IQR: 2.52-2.99; [p < 0.01]). Conclusion: Speckle-tracking echocardiography showed that left ventricular myocardial longitudinal strain was impaired in the RA patients.

Original languageEnglish
Article numberFSO396
JournalFuture Science OA
Volume5
Issue number6
DOIs
Publication statusPublished - 2019

Keywords

  • cardiovascular disease
  • cardiovascular risk
  • carotid ultrasound
  • disease activity
  • echocardiography
  • myocardial alterations
  • noninvasive methods
  • rheumatoid arthritis
  • speckle tracking echocardiography
  • ventricular alterations

ASJC Scopus subject areas

  • Biotechnology

Fingerprint Dive into the research topics of 'Noninvasive imaging methods for evaluating cardiovascular involvement in patients with rheumatoid arthritis before and after anti-TNF drug treatment'. Together they form a unique fingerprint.

  • Cite this